https://www.selleckchem.com/pr....oducts/gilteritinib-
The current evidence supports that βC alkaloids offer potential therapeutic agents against most of these disorders and amenable for further drug design.Chronic kidney disease (CKD) involves interstitial fibrosis as an influential underlying pathological process associated with compromised renal function regardless of etiological cause of the injury. The tubulointerstitial fibrosis is found to be well correlated with declining renal function and its subsequent culmination into renal failure. Given the prominent role of throm
Like
Comment
Share
